Castle Biosciences acquires spatial biology company Cernostics
Cernostics' TissueCypher platform leverages an approach that consolidates important elements of AI to deliver the spatialomics revolution to…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Dec 21
Cernostics' TissueCypher platform leverages an approach that consolidates important elements of AI to deliver the spatialomics revolution to…
07 Dec 21
The contract with Vizient — whose members represent more than half of the hospitals and health systems in…
07 Dec 21
Embecta will be an independent, publicly-traded company, upon the completion of the transaction
07 Dec 21
The Galleri multi-cancer early detection test can detect more than 50 types of cancers
06 Dec 21
Through its CKI subsidiary, ClaroNav has received the regulatory approval for its Navient ENT and Navient Cranial as…
06 Dec 21
By delivering results within one hour, the test provides a rapid and cost-effective solution for identifying the Omicron…
06 Dec 21
The tests deploy quantitative polymerase chain reaction (qPCR) technology to improve variant detection and viral research
06 Dec 21
Pixee Medical's Knee+ AR computer-assisted orthopedic solution deployed for the first-ever use in the United States with the…
06 Dec 21
The QuantiFERON® SARS-CoV-2 assay detects CD4+ and CD8+ T-cell responses, thereby enabling a much more comprehensive assessment of…
06 Dec 21
ImageMover offers a workflow solution to capture unscheduled and non-radiology images and videos at the point-of-care